Dear Working Group member,  

We are pleased to invite you for the upcoming Pharma Working Group meeting, which will take place on Wednesday 15^th Jan., 2014 from 4:30pm at the European Chamber offices in Shanghai and Beijing with video conference facility.

At this meeting, we have the honour to invite Ms. Valérie PARIS, Economist - Health Division, Organisation for Economic Co-operation and Development (OECD) to talk about « Trends in pharmaceutical reimbursement and pricing policies in OECD countries and perspectives for China ». The presentation will describe recent trends in pharmaceutical R&P policies in OECD countries, with a focus on “value-based pricing”, based on the study published by the OECD in 2013. It will stress the most relevant aspects for China.

Tentative Agenda

16:30-16:40         Opening remark by the Chair
16:40-17:30         Presentation by Ms. Valérie PARIS, from OECD, on « Trends in pharmaceutical reimbursement and pricing policies in OECD countries and perspectives for China ».
17:30-18:30         Q&A

Short Bio of Ms. Valérie PARIS, Economist - Health Division, Organisation for Economic Co-operation and Development (OECD)Valérie Paris joined the OECD Secretariat in September 2005 to contribute to the work undertaken by the Health Division. Since then, she has contributed to several projects on health systems’ characteristics and performance and on pharmaceutical policies.

Previously, she was researcher at the French Institute of Research and Information on Health Economics (IRDES), a non-for-profit organization. She participated in research projects on pharmaceutical policies, physicians’ payment schemes, health accounts and comparative analysis of health systems.
She holds a master’s degree in Economics, statistics and econometrics from the University of Paris 1-Sorbonne (1990).
Recent publications:
·         Paris V. and A. Belloni (2013), Value in pharmaceutical pricing, OECD Health Working Paper, No. 63.
·         OECD (2010), Value for Money in health spending, OECD, Paris (author of two chapters on use of health technology assessment and pharmaceutical policies)
·         Gay J., Paris V., Devaux M., de Looper M. (2011), ‘Mortality amenable to health care in 31 OECD countries: estimates and methodological issues’, OECD Health Working Paper, No. 55.
·         Paris V., Devaux M. and L. Wei (2010), ‘Health systems characteristics’, OECD Health Working Paper, No. 50.
·         OECD (2008), Pharmaceutical Pricing Policies in a Global Market, OECD Health Policy Studies, Paris, OECD (authors: E. Docteur, V. Paris and P. Moïse).

For more information about the speaker, please also refer to:
http://www.oecd.org/health/pharmaceuticalpricingpolicyproject.htm
http://www.oecd.org/health/valueinpharmaceuticalpricing.htm

Please kindly register by replying to Dr. Xin-Ying Ren at xyren@europeanchamber.com.cn by noon 14 January 2014 indicating whether you will attend in Beijing or in Shanghai or dial in.
For people who could not attend at both venues, the dial-in Number is: +86-21- 6120 6622, Participation Code: *181938* (press * key before and after)

Downloads

Contact